Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Hansa Biopharma
Sort By
Newest First
1 / 1
1 / 1
Agreement
Hansa Biopharma Announces Exclusive Agreement with Sarepta Therapeutics to Develop Imlifidase as Pre-treatment Ahead of Gene Therapy
Sarepta Therapeutics, Inc
PR-M07-20-NI-004
Jul 03, 2020
